ResMed
665 hedge funds and large institutions have $21.6B invested in ResMed in 2020 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 242 increasing their positions, 228 reducing their positions, and 70 closing their positions.
50% more call options, than puts
Call options by funds: $65.5M | Put options by funds: $43.8M
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
6% more funds holding
Funds holding: 628 → 665 (+37)
8% more capital inflows, than outflows
Capital inflows: $843M | Capital outflows: $781M
6% more repeat investments, than reductions
Existing positions increased: 242 | Existing positions reduced: 228
4% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 70
0.43% more ownership
Funds ownership: 69.58% → 70.01% (+0.43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AKO Capital
London,
United Kingdom
|
+$71M |
| 2 |
HSBC Holdings
London,
United Kingdom
|
+$70.1M |
| 3 |
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$64.4M |
| 4 |
BlackRock
New York
|
+$47.9M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$38.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Zurich Insurance Group
Zurich,
Switzerland
|
-$65.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$53.2M |
| 3 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
-$49.4M |
| 4 |
Janus Henderson Group
London,
|
-$45.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$40.8M |
RMD Hedge Fund Activity: Q4 2020 in Review
665 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2020, worth a combined $21.6B — up 25% from $17.3B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new RMD positions and 70 closed out — a net gain of 3 holders — while 242 added to existing stakes and 228 trimmed.
The largest buyer was AKO Capital, opening a new position worth an estimated $71M. The largest seller was Zurich Insurance Group, cutting an estimated $65.5M.
- 665 institutional investors held ResMed (RMD) as of Q4 2020, up from 628 in Q3 2020.
- Funds reported $21.6B of ResMed stock for Q4 2020, up 25% quarter-over-quarter.
- 73 funds opened new ResMed positions in Q4 2020 and 70 closed out, a net change of +3 holders.
- The largest ResMed buyer in Q4 2020 was AKO Capital, an estimated $71M added.
- The largest ResMed seller in Q4 2020 was Zurich Insurance Group, an estimated $65.5M sold.
Based on aggregated 13F filings for Q4 2020.